These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3496380)

  • 1. The induction of lymphokine synthesis and cell growth in IL 3-dependent cell lines using antigen-antibody complexes.
    Le Gros GS; Le Gros JE; Watson JD
    J Immunol; 1987 Jul; 139(2):422-8. PubMed ID: 3496380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4.
    Hültner L; Moeller J; Schmitt E; Jäger G; Reisbach G; Ring J; Dörmer P
    J Immunol; 1989 May; 142(10):3440-6. PubMed ID: 2785556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 regulates the expression of IL 2 receptors on interleukin 3-dependent bone marrow-derived cell lines.
    Le Gros GS; Shackell PS; Le Gros JE; Watson JD
    J Immunol; 1987 Jan; 138(2):478-83. PubMed ID: 3098845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mast cell growth factor (MCGF-3) produced by marrow-adherent cells that synergizes with interleukin 3 and interleukin 4.
    Boswell HS; Mochizuki DY; Burgess GS; Gillis S; Walker EB; Anderson D; Williams DE
    Exp Hematol; 1990 Aug; 18(7):794-800. PubMed ID: 2379544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of infection with murine recombinant retroviruses containing the v-src oncogene on interleukin 2- and interleukin 3-dependent growth states.
    Watson JD; Eszes M; Overell R; Conlon P; Widmer M; Gillis S
    J Immunol; 1987 Jul; 139(1):123-9. PubMed ID: 3495596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for specific receptors for interleukin 3 on lymphokine-dependent cell lines established from long-term bone marrow cultures.
    Palaszynski EW; Ihle JN
    J Immunol; 1984 Apr; 132(4):1872-8. PubMed ID: 6421927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse bone marrow-derived IL-3-dependent mast cells and autonomous sublines produce IL-6.
    Hültner L; Szöts H; Welle M; Van Snick J; Moeller J; Dörmer P
    Immunology; 1989 Jul; 67(3):408-13. PubMed ID: 2788129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow adherent cell hemopoietic growth factor production.
    Quesenberry P; Song Z; Alberico T; Gualtieri R; Stewart M; Innes D; McGrath E; Cranston S; Kleeman E
    Prog Clin Biol Res; 1985; 184():247-56. PubMed ID: 3931091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
    Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
    Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production of lymphokines by primary alloreactive T-cell clones: a co-ordinate analysis of 233 clones in seven lymphokine assays.
    Sanderson CJ; Strath M; Warren DJ; O'Garra A; Kirkwood TB
    Immunology; 1985 Dec; 56(4):575-84. PubMed ID: 3935571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines.
    Thalmeier K; Meissner P; Reisbach G; Hültner L; Mortensen BT; Brechtel A; Oostendorp RA; Dörmer P
    Exp Hematol; 1996 Jan; 24(1):1-10. PubMed ID: 8536785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
    Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
    Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characteristics of cell lines requiring interleukin 3 for growth.
    Ihle JN; Keller J; Greenberger JS; Henderson L; Yetter RA; Morse HC
    J Immunol; 1982 Oct; 129(4):1377-83. PubMed ID: 6809821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A.
    Rumsaeng V; Vliagoftis H; Oh CK; Metcalfe DD
    J Immunol; 1997 Feb; 158(3):1353-60. PubMed ID: 9013979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF).
    Caruana G; Ashman LK; Fujita J; Gonda TJ
    Exp Hematol; 1993 Jun; 21(6):761-8. PubMed ID: 7684700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.
    Ihle JN; Keller J; Oroszlan S; Henderson LE; Copeland TD; Fitch F; Prystowsky MB; Goldwasser E; Schrader JW; Palaszynski E; Dy M; Lebel B
    J Immunol; 1983 Jul; 131(1):282-7. PubMed ID: 6190911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF.
    Yung YP; Moore MA
    J Immunol; 1982 Sep; 129(3):1256-61. PubMed ID: 6809816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification of a mast cell growth-enhancing activity and its separation from IL-3 and IL-4.
    Moeller J; Hültner L; Schmitt E; Dörmer P
    J Immunol; 1989 May; 142(10):3447-51. PubMed ID: 2785557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.